BRAF mutation in papillary thyroid carcinoma: Predictive value for long-term prognosis and radioiodine sensitivity

European Annals of Otorhinolaryngology, Head and Neck Diseases

Volumn 131, Issue 1, 2014, Pages 7-13

  Zoghlami, A ^a   Roussel, F ^a   Sabourin, J C ^a   Kuhn, J M ^a   Marie, J P ^a   Dehesdin, D ^a   Choussy, O ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

Author keywords

BRAF V600E mutation; Papillary thyroid carcinoma; Prognosis; Recurrence

Indexed keywords

B RAF KINASE; RADIOACTIVE IODINE; BRAF PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CERVICAL LYMPH NODE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GENDER; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE METASTASIS; THYROID CARCINOMA; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME; CARCINOMA; GENETICS; MUTATION; PROGNOSIS; RISK FACTOR; THYROID NEOPLASMS; TIME; TREATMENT FAILURE;

ADULT; CARCINOMA; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MUTATION; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTO-ONCOGENE PROTEINS B-RAF; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS; TIME FACTORS; TREATMENT FAILURE;

EID: 84895499009     PISSN: 18797296     EISSN: 1879730X     Source Type: Journal    
DOI: 10.1016/j.anorl.2013.01.004     Document Type: Article

References (25)

1. L. Leenhardt, and P. Grosclaude Epidemiology of thyroid carcinoma over the world Ann Endocrinol (Paris) 72 2 2011 136 148
2. M. Xing BRAF mutation in thyroid cancer Endocr Relat Cancer 12 2 2005 245 262
3. J. Albores-Saavedra, D.E. Henson, and E. Glazer et al. Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype-papillary, follicular, and anaplastic: a morphological and epidemiological study Endocr Pathol 18 1 2007 1 7
4. E.L. Mazzaferri, and S.M. Jhiang Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Am J Med 97 5 1994 418 428
5. E.L. Mazzaferri, and R.T. Kloos Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer J Clin Endocrinol Metab 86 4 2001 1447 1463
6. Y. Ito, A. Miyauchi, and T. Jikuzono et al. Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping World J Surg 31 4 2007 838 848
7. N. Döbert, C. Menzel, and S. Oeschger et al. Differentiated thyroid carcinoma: the new UICC 6th edition TNM classification system in a retrospective analysis of 169 patients Thyroid 14 1 2004 65 70
8. V. Trovisco, P. Soares, and A. Preto et al. Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness Virchows Arch 446 6 2005 589 595
9. M.N. Nikiforova, E.T. Kimura, and M. Gandhi et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas J Clin Endocrinol Metab 88 11 2003 5399 5404
10. C. Lupi, R. Giannini, and C. Ugolini et al. Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma J Clin Endocrinol Metab 92 11 2007 4085 4090
11. M. Xing, W.H. Westra, and R.P. Tufano et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer J Clin Endocrinol Metab 90 12 2005 6373 6379
12. L. Fugazzola, D. Mannavola, and V. Cirello et al. BRAF mutations in an Italian cohort of thyroid cancers Clin Endocrinol (Oxf) 61 2 2004 239 243
13. Y. Ito, H. Yoshida, and R. Maruo et al. BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients Endocr J 56 1 2009 89 97
14. J.H. Lee, E.S. Lee, and Y.S. Kim Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis Cancer 110 1 2007 38 46
15. T.H. Kim, Y.J. Park, and J.A. Lim et al. The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis Cancer 118 7 2012 1764 1773
16. M.E. Girelli, D. Casara, and D. Rubello et al. Differentiated thyroid carcinoma (DTC) in the elderly: disease outcome, therapeutic approach, and long-term results in a group of 314 patients J Endocrinol Invest 22 10 Suppl. 1999 45 46
17. C. Ugolini, R. Giannini, and C. Lupi et al. Presence of BRAF V600E in very early stages of papillary thyroid carcinoma Thyroid 17 5 2007 381 388
18. I. Sedliarou, V. Saenko, and D. Lantsov et al. The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma Int J Oncol 25 6 2004 1729 1735
19. R. Elisei, C. Ugolini, and D. Viola et al. BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study J Clin Endocrinol Metab 93 10 2008 3943 3949
20. M. Cañadas Garre, M. López de la Torre Casares, and P. Becerra Massare et al. BRAF(T1799A) mutation in the primary tumor as a marker of risk, recurrence, or persistence of papillary thyroid carcinoma Endocrinol Nutr 58 4 2011 175 184
21. C.J. O'Neill, M. Bullock, and A. Chou et al. BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer Surgery 148 6 2010 1139 1145
22. - targeting to the membrane Endocr Relat Cancer 13 1 2006 257 269
23. C. Durante, E. Puxeddu, and E. Ferretti et al. BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism J Clin Endocrinol Metab 92 7 2007 2840 2843
24. G. Oler, and J.M. Cerutti High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes Cancer 115 5 2009 972 980
25. C. Mian, S. Barollo, and G. Pennelli et al. Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake Clin Endocrinol (Oxf) 68 1 2008 108 116